
IndraLab
Statements
Hydroxychloroquine activates immune response. 17 / 17
|
3
14
reach
"By adding dual RAS blocker, we would be treating COVID-19 with three different pathways : the antiviral reduces the viral load, HCQ blocks the entry of Sars Cov2 via ACE2 blockade and modulate immunity, and the ACEi plus ARBs plus tetanus-diphtheria vaccine inhibits and modulates the RAS dependent immune response."
| PMC
reach
"Based on the evidence that hydroxychloroquine and chloroquine inhibit lysosome turnover, and consequently the antigen presentation initiating the immune response,38 there has been a large empirical use of antimalarial drugs at the beginning of the pandemic with the purpose to damper the adverse events and the hospitalization duration."
| PMC
reach
"Hydroxychloroquine prevented the induction of epigenetic modifications needed for trained immunity.81 Preoperative exercise therapy triggered an anti‐inflammatory trained immunity phenotype via metabolic reprogramming and led to attenuation of liver injury and inflammation from ischemia in mouse models.82 Sterile tissue injury trained the innate immune system, providing protection against subsequent infection in adult drosophila."